Centrioles are essential for the formation of microtubulederived structures, including cilia and centrosomes. Abnormalities in centrosome number and structure occur in many cancers and are associated with genomic instability [1] . In most dividing animal cells, centriole formation is coordinated with DNA replication and is highly regulated such that only one daughter centriole forms close to each mother centriole [1, 2] . Centriole formation is triggered and dependent on a conserved kinase, SAK/PLK4 [3] [4] [5] [6] [7] [8] . Downregulation and overexpression of SAK/PLK4 is associated with cancer in humans, mice, and flies [9] [10] [11] . Here we show that centrosome amplification is normally inhibited by degradation of SAK/PK4 degradation, mediated by the SCF/ Slimb ubiquitin ligase. This complex physically interacts with SAK/PLK4, and in its absence, SAK/PLK4 accumulates, leading to the striking formation of multiple daughter centrioles surrounding each mother. This interaction is mediated via a conserved Slimb binding motif in SAK/PLK4, mutations of which leads to centrosome amplification. This regulation is likely to be conserved, because knockout of the ortholog of Slimb, b-Trcp1 in mice, also leads to centrosome amplification [12] . Because the SCF/b-Trcp complex plays an important role in cell-cycle progression, our results lead to new understanding of the control of centrosome number and how it may go awry in human disease.
Results and Discussion
Two ubiquitin ligases, the SKP1-CUL1-F-box-protein (SCF) complex and the anaphase-promoting complex/cyclosome (APC/C), ubiquitylate many cell-cycle regulators, assuring irreversibility in cell-cycle transitions [13, 14] . Previous work suggested the SCF complex and protein degradation to be important players in the control of centrosome number [15] [16] [17] [18] . These complexes comprise three polypeptides-Skp1 (SkpA in Drosophila), Cullin1/3, and Roc1/Rbx1-and a fourth variable adaptor that recognizes substrates, the F-box protein [13, 19] . Skp1 and Cul1 localize to the centrosome [17] . Furthermore, depletion of SkpA and the F-box protein, Slimb in Drosophila and its ortholog b-Trcp1 in mice, leads to a dramatic increase in centrosome number and abnormal mitotic spindles [12, 15, 16] . However, these results may not reflect direct regulation of centriole number but merely the diverse roles of the SCF complex in cell-cycle control [13] . This led us to investigate the role of protein degradation in centriole biogenesis, and in particular, the role of the SCF/Slimb complex.
We first investigated changes in centrosome number in cultured Drosophila cells after depletion of Slimb and SkpA. We used Geminin, an inhibitor of licensing of DNA replication, as a positive control for changes in centrosome number. This is because depletion of Geminin in human cells leads to DNA rereplication, associated with centrosome amplification [20] . Indeed, Geminin RNAi led to an increase in the proportion of cells with more than two centrosomes in Drosophila cells (Figures S1A and S1B available online) and large nuclei as expected after DNA rereplication (Figures S1A, S2A, and S2B). RNAi of Slimb and SkpA in the same time-frame resulted in changes in cell-cycle profile (Figures S1C and S1D) and a similar increase in the proportion of cells with more than two centrosomes ( Figures S1A and S1B ). An increase in centrosome number after Slimb and SkpA depletion could result from aborted mitosis, aborted cytokinesis, or a block in S phase, and so be independent of direct changes in the centrosome duplication machinery. The different cell-cycle profiles seen after downregulation of SkpA and Slimb ( Figure S1D ) are likely to reflect the diverse roles played by multiple SkpA-containing SCF complexes in the degradation of several cell-cycle regulators [13] . Those differences and the lack of any significant increase in the proportion of mitotic (not shown) and polyploid cells after Slimb depletion ( Figures S1D and S2B ) suggest that the observed increase in centrosome number is unlikely to arise indirectly because of abnormal cell-cycle progression. We therefore conclude that downregulation of SkpA or Slimb is likely to lead to impaired degradation of a common substrate that regulates centriole duplication with consequent centrosome amplification. Strikingly, depletion of Slimb led to a very specific phenotype at the electron microscope level ( Figure 1A) . We observed more than one daughter centriole budding from a single mother, which is not normally seen in cycling cells, where there is strict limit to one single daughter per mother centriole. A similar phenotype is also observed upon overexpression of SAK/PLK4 and SAS-6 [3, 7, 21] , a molecule known to be downstream of SAK/PLK4 and to induce centrosome amplification upon overexpression [5, 21, 22] . Those rosette-like structures are reminiscent to the ones observed in multiciliated epithelial cells, which express high levels of SAK/PLK4 and SAS-6 [23, 24] , and where as many as 300 centrioles/basal bodies are formed per cell.
We investigated whether the SCF/Slimb complex was targeting SAK/PLK4 or SAS-6 for degradation by asking whether their protein levels were higher in the absence of Slimb or SkpA. Because the levels of endogenous SAK/PLK4 are extremely low and difficult to detect by western blotting [6, 7] , we used a stable cell line in which SAK/PLK4 was fused with Protein A and could be expressed from the inducible metallothionein promoter. We investigated levels of SAK/ PLK4 after induction of its expression by culture in medium containing CuSO 4 for 15 hr. SAK/PLK4 levels were considerably higher after downregulation of SkpA and Slimb, but not of Geminin or other F-box proteins ( Figure 1B ; Figure S2C ). The increase in levels of SAK/PLK4 that we see after downregulation of the SCF/Slimb complex contrasts with the lack of effect on the levels of SAS-6 protein ( Figure S3 ). This result is consistent with a recent report that human SAS-6 is degraded by the APC/Cdh1 [21] and suggests that the centrosome amplification observed after Slimb depletion is due to impaired SAK/PLK4 degradation.
We further investigated the regulation of SAK/PLK4 levels by the SCF/Slimb complex. We followed SAK/PLK4 levels during a period of 8 hr after induction of its expression for 15 hr, with subsequent removal of CuSO 4 prior to the time course. Whereas SAK/PLK4 degradation had commenced 4 hr after removal of CuSO 4 from control cells, its degradation began only after 8 hr in Slimb-depleted cells ( Figure 1C ). We verified this result investigating the endogenous SAK/PLK4 by developing a sensitive immunocytochemical detection system for this protein. SAK/PLK4 levels and localization might be cellcycle regulated, as they are for other members of the polo kinase family, so we made all comparisons by examining cells at the same cell-cycle stage (metaphase). Slimb depletion resulted in an increase in the levels of the endogenous SAK/ PLK4 at the centrosome and the whole cell, and thus our results are unlikely to reflect abnormal localization properties of SAK/PLK4 (Figures 1D and 1E; Figures S4 and S5A ). This is also unlikely to be an indirect consequence of an increase in the number of centrosomes at each pole after Slimb RNAi, because we also saw more intense SAK/PLK4 staining without any increase in the size of poles ( Figure S5B , upper pole). This suggests that the centrosome amplification seen after Slimb RNAi results from an increase in SAK/PLK4 levels. To further verify these results, we used a dominant-negative approach. Slimb binds to SkpA through its F-box and mutants in this domain have been shown to impair SCF/Slimb function [25] . Indeed, we observed elevated levels of the SAK/PLK4 protein after expression of such a mutant (Figure 2A) , which is accompanied by more than a 2-fold increase in the proportion of cells with more than two centrosomes (68.2 6 1.1 after transfection of Slimb DF-HA versus 32.3 6 2.5 with HA alone).
If Slimb is targeting SAK/PLK4 for degradation, then the increase in centrosome number seen after impairment of Slimb function should depend on SAK/PLK4. We performed double RNAi of SAK/PLK4 and either Slimb or SkpA. We observed a reduction in centrosome number after both Slimb and SAK/PLK4 RNAi, and after both SkpA and SAK/PLK4 RNAi, as compared to Slimb and SkpA alone, suggesting that the phenotype observed after depletion of the Slimb and SkpA is dependent on the presence of SAK/PLK4, corroborating our hypothesis ( Figures 2B and 2C) . SCF ubiquitin ligases tag proteins with a polyubiquitin chain that targets them for degradation by the 26S proteasome [19] . We tested whether SAK/PLK4 is degraded by the 26S proteasome. We observed degradation of SAK/PLK4 in the absence but not in the presence of MG132, a 26S proteasome inhibitor, for 8 hr ( Figure 3A) . We observed an approximate 3-fold increase in the levels of endogenous SAK/PLK4 at the metaphase centrosome when we inhibited proteasome activity ( Figures 3B and 3C ). This was also reflected in the total centrosome number, as cells accumulated centrosomes after such MG132 treatment (Figures 3D and 3E) . Together, these results strongly suggest that SAK/PLK4 is degraded by the proteasome and that impairment of this regulation leads to centrosome amplification. F-box proteins are known to bind directly to SCF substrates through a WD40 repeat motif [13] . To determine whether there is an association between SAK/PLK4 and Slimb, we built two cell lines in which these proteins were tagged with Protein A. We used immunoglobulin-coated beads to purify each of these proteins and the proteins associated with them. Complexes were subjected to SDS-PAGE and individual bands identified by mass spectrometry. We were able to identify and Slimb-Myc (constitutive). S, input/supernatant after cell lysis; E, bead eluate; protein ladder is in middle lane (marked by asterisk). Western was first members of the Slimb/SCF complex, including the subunits Slimb, SkpA, and Cul-1, after pull-down of SAK/PLK4 (Figure 4A) . Conversely, endogenous SAK/PLK4 was identified in the pull-down of protein-A-tagged Slimb ( Figure 4A ). The pull-down included other proteins (data not shown) among which was Period, a known interactor of Slimb [25] . We have used a cell line expressing protein A as a negative control and did not find any of those molecules (data not shown). Moreover, we have performed similar experiments to purify other cell-cycle protein complexes and have never identified SAK/PLK4 (data not shown).
Substrates of the SCF/Slimb complex show a conserved degron that is recognized by Slimb [13] . We found that SAK/PLK4 protein has a modified Slimb recognition site in Drosophila (DSGIIT; position 293) and humans (DSGHAT; position 285) ( Figure 4B) . In previous studies, human SAK/PLK4 was shown to be ubiquitinated [26] and removal of a region encompassing amino acids 272-311 led to stabilization of the human SAK/ PLK4, although no analysis was performed on centrosome number [27] . We mutated the conserved Slimb recognition site to DAGIIA in Drosophila SAK/PLK4, which we called SAK-ND (nondegradable). This mutation abolished SAK's ability to interact with Slimb (Figures 4B and 4C ; Figure S6A ) and led to a decrease in SAK's ubiquitinated species ( Figure S6B) . Moreover, SAK-ND is more stable in comparison to its WT counterpart ( Figure 4D ). Thus, this mutation allowed us to test the biological significance of SAK/PLK4 degradation by the SCF/Slimb complex. Upon expression of the mutated SAK/PLK4 construct ( Figure 4E ), we observed a very similar phenotype to the one registered after Slimb RNAi (Figure 1A) , i.e, rosette-like structures. These structures contained centriole percursors ( Figure 4E , top) or elongating centrioles (Figure 4E, middle and bottom) . Those results suggest a common centriole-amplification phenotype observed after Slimb RNAi and after expression of the SAK-ND mutant. The observation of at least five centrioles clustered at spindle poles in mitosis suggests that some of the supranumerary centrioles formed in one cycle after impairment of SAK/PLK4 degradation by the SCF/Slimb complex become proper microtubule-organizing centers ( Figure S6C) . We quantified the formation of supranumerary centrosomes at the light microscope level. Upon transient low-level expression of the SAK-ND construct fused to GFP, we systematically observed a statistical significant increase in centrosome number in transfected cells compared to cells expressing low levels of the WT SAK fused to GFP ( Figure 4F ; Figure S6D ). Indeed, expression of low levels of SAK-ND led to a 2-fold increase in centrosome amplification ( Figure 4F ). This is comparable to the effect of Slimb RNAi ( Figure S1B ) and after expression of a dominant-negative form of Slimb (referred to above), suggesting that high levels of SAK/PLK4 underlie those phenotypes.
Together, our results show that degradation of SAK/PLK4 by the SCF/Slimb complex is critical to restrict its function, preventing centrosome amplification. Although other mechanisms for regulation of SAK/PLK4 activity may exist, proteolytic degradation is likely to be conserved across species and be relevant in the animal. The Slimb-binding phosphodegron in SAK/PLK4 is conserved in vertebrates ( Figure 4B) . Moreover, knockout of the ortholog of Slimb in mice, bTrcp1, and both SkpA and Slimb Drosophila mutants show an increase in centrosome number [12, 15, 16] , as do flies that overexpress SAK/PLK4 [4, 5, 10] .
It has been suggested that centriole overduplication is normally prevented by a ''licensing event,'' the disengagement of centrioles that occurs at the exit of mitosis, required for the next duplication cycle [28, 29] . Requirement for this event ensures that centrioles duplicate only once in every cell cycle. However, it was recently shown that centriole amplification can also occur through the simultaneous formation of many daughters from a single mother, as it is after overexpression of SAK/PLK4 [3] [4] [5] 7] and SAS-6 [21] or inhibition of proteolysis by the proteosome [18] . Our data suggests that proteolysis mediated by SCF/Slimb plays an important role in limiting the amount of SAK/PLK4, but not SAS-6, available to trigger multiple daughter formation. When SAK/PLK4 is not degraded, multiple daughter centrioles may be generated, which led to centrosome amplification ( Figures 4E, 4F, and 4G) . The regulation of centriole number thus emerges as a multistep mechanism, where proteolysis controls the activity of key players, SAK/PLK4 and SAS-6 [18, 21] .
The mammalian F-box counterpart of Slimb, b-Trcp, plays a role in the DNA damage response by halting the cycle in response to genotoxic inputs [30] [31] [32] . Misregulation of b-Trcp has been observed in cancer cells [13, 33] in which centrosome number is often increased after stress [1] . It is thus possible that Slimb/b-Trcp coordinates checkpoints that monitor the status of DNA replication with centrosome number. The misregulation of this F-box protein would therefore result in changes in levels of SAK/PLK4, which are associated with mitotic abnormalities and oncogenesis [6, 9, 10] . Given that other substrates of the Slimb/b-Trcp F-box protein require to be phosphorylated and our own results with the SAK-ND mutant ( Figures 4C-4E) , it is likely that SAK/PLK4 also requires such a modification at the serine and threonine residues in its DSGIIT degron to mark it for degradation. Future research on the identity and regulation of the kinase that phosphorylates SAK/PLK4 and on the localization of Slimb and SAK/PLK4 phosphorylated at the DSGIIT degron should indicate how different signaling events are probed for Myc to detect Slimb-Myc and then for protein A to show SAK and SAK-ND. a-tubulin was used as a loading control. Note that both cell lines express similar levels of Slimb-Myc and ProtA-SAK or ProtA-SAK-ND (see Figure S6A ), but that the latter brings down much less Slimb-Myc. Figure S6D for images). The proportion of cells with more than two centrosomes in interphase cells was counted and normalized over controls (ratio is equal to 1 in GFP-only transfected controls). Data are the average of three experiments 6 SEM. The increase in the population of cells with more than two centrosomes after SAK-ND transfection is statistically different from the one observed after transfection of WT SAK/PLK4 (odds ratio of 3.5; p < 10 215 , Pearson's c 2 test) (G) Regulation of the levels of SAK/PLK4 by the SCF/Slimb complex. The levels of SAK/PLK4 have to be very well controlled. Overexpression of SAK/PLK4, or depletion of the SCF/Slimb complex, which led to SAK/PLK4 accumulation, results in centrosome amplification through simultaneous multiple procentriole formation. coordinated in the cell to prevent centrosome amplification. Our results open new avenues for understanding the mechanisms underlying centrosome misregulation that are of direct relevance to human disease.
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